lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Ask supplier a question | View on supplier's website

Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2330
Sku #	A2330-1mg*5
Pricing	1mg*5, $790.00

Feedback